Drug Cos. Made Record Pay-For-Delay Deals In 2011: FTC
Pharmaceutical companies racked up record numbers of so-called reverse payment patent settlements in 2011 designed to delay the release of a rival generic drug, the Federal Trade Commission said Tuesday, calling...To view the full article, register now.
Already a subscriber? Click here to view full article